Cargando…
Retinoblastoma genetics in India: From research to implementation
Retinoblastoma is the prototypic genetic cancer. India carries the biggest burden of retinoblastoma globally, with an estimated 1500 new cases annually. Recent advances in retinoblastoma genetics are reviewed, focusing specifically on information with clinical significance to patients. The Indian li...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448234/ https://www.ncbi.nlm.nih.gov/pubmed/25971166 http://dx.doi.org/10.4103/0301-4738.156917 |
_version_ | 1782373674533257216 |
---|---|
author | Dimaras, Helen |
author_facet | Dimaras, Helen |
author_sort | Dimaras, Helen |
collection | PubMed |
description | Retinoblastoma is the prototypic genetic cancer. India carries the biggest burden of retinoblastoma globally, with an estimated 1500 new cases annually. Recent advances in retinoblastoma genetics are reviewed, focusing specifically on information with clinical significance to patients. The Indian literature on retinoblastoma clinical genetics is also highlighted, with a comment on challenges and future directions. The review concludes with recommendations to help clinicians implement and translate retinoblastoma genetics to their practice. |
format | Online Article Text |
id | pubmed-4448234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44482342015-06-11 Retinoblastoma genetics in India: From research to implementation Dimaras, Helen Indian J Ophthalmol Review Article Retinoblastoma is the prototypic genetic cancer. India carries the biggest burden of retinoblastoma globally, with an estimated 1500 new cases annually. Recent advances in retinoblastoma genetics are reviewed, focusing specifically on information with clinical significance to patients. The Indian literature on retinoblastoma clinical genetics is also highlighted, with a comment on challenges and future directions. The review concludes with recommendations to help clinicians implement and translate retinoblastoma genetics to their practice. Medknow Publications & Media Pvt Ltd 2015-03 /pmc/articles/PMC4448234/ /pubmed/25971166 http://dx.doi.org/10.4103/0301-4738.156917 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Dimaras, Helen Retinoblastoma genetics in India: From research to implementation |
title | Retinoblastoma genetics in India: From research to implementation |
title_full | Retinoblastoma genetics in India: From research to implementation |
title_fullStr | Retinoblastoma genetics in India: From research to implementation |
title_full_unstemmed | Retinoblastoma genetics in India: From research to implementation |
title_short | Retinoblastoma genetics in India: From research to implementation |
title_sort | retinoblastoma genetics in india: from research to implementation |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448234/ https://www.ncbi.nlm.nih.gov/pubmed/25971166 http://dx.doi.org/10.4103/0301-4738.156917 |
work_keys_str_mv | AT dimarashelen retinoblastomageneticsinindiafromresearchtoimplementation |